Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects
Amélie Lothe(Lyon 1 Université), Philippe Ryvlin(University Hospital of Lausanne), Philip Gorwood(Inserm), Nicolas Costes(Centre d'Exploration et de Recherche Médicale par Emission de Positons), F. Lávenne(Centre d'Exploration et de Recherche Médicale par Emission de Positons), Claudette Boni(Inserm), Sandrine Bouvard, Didier Le Bars(Centre d'Exploration et de Recherche Médicale par Emission de Positons)
Cited by 24
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k
Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa
|Nature Genetics|2019|1.2k
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study
|The Lancet Neurology|2013|1.1k